biote Corp.

Total Valuation

biote Corp. carries a market capitalization of 47.86M, placing it among publicly traded companies globally. Its enterprise value stands at 177.35M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

biote Corp. currently has 27.66M shares outstanding.

Valuation Ratios

biote Corp. trades at a trailing price-to-earnings ratio of 9.79. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at -0.79.

Enterprise Valuation

On an enterprise value basis, biote Corp. trades at an EV/EBITDA multiple of 9.53 and an EV/FCF ratio of 5.02. The EV/Sales ratio of 0.97 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 12.02 provides insight into valuation relative to core operating earnings.

Financial Position

biote Corp. maintains a current ratio of 1.43, meaning it holds 1.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -221.06, indicating conservative leverage, while an interest coverage ratio of 1.99 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Over the trailing twelve months, biote Corp. has paid 3.18M in income taxes, reflecting an effective tax rate of 30.98.

Stock Price Statistics

biote Corp.'s stock has declined approximately -62.96928% over the past 52 weeks. The 50-day moving average sits at 1.36, while the 200-day moving average is 1.90.

Income Statement

Over the trailing twelve months, biote Corp. generated 183.53M in revenue and converted that into 5.86M in net income, yielding earnings per share of 0.21. EBITDA reached 18.60M, while operating income came in at 14.75M.

Balance Sheet

biote Corp. holds 11.17M in cash and equivalents against 128.64M in total debt, resulting in a net debt position of 110.33M. Total book value stands at -65.79M, with working capital of 12.94M providing operational flexibility.

Cash Flow

biote Corp. produced 24.37M in operating cash flow over the past twelve months. After subtracting -4.49M in capital expenditures, free cash flow totaled 19.87M - equivalent to 0.66 per share.

Margins

biote Corp. operates with a gross margin of 68.58, reflecting its pricing power and cost economics. The operating margin of 8.04 and net profit margin of 3.19 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 14.05 indicates the proportion of earnings distributed to shareholders.

Scores

biote Corp. posts an Altman Z-Score of 2.22, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.